HK1249046A1 - 治療b型肝炎病毒的方法 - Google Patents

治療b型肝炎病毒的方法

Info

Publication number
HK1249046A1
HK1249046A1 HK18108874.4A HK18108874A HK1249046A1 HK 1249046 A1 HK1249046 A1 HK 1249046A1 HK 18108874 A HK18108874 A HK 18108874A HK 1249046 A1 HK1249046 A1 HK 1249046A1
Authority
HK
Hong Kong
Prior art keywords
virus
methods
treating hepatitis
hepatitis
treating
Prior art date
Application number
HK18108874.4A
Other languages
English (en)
Inventor
Aguayo Esmeralda
Appleby Todd
Birkus Gabriel
Cheng Guofeng
Dornan David
Kobayashi Tetsuya
Charles Mello Christopher
Schmitz Uli
WILLKOM Madeleine
Yu Mei
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1249046A1 publication Critical patent/HK1249046A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18108874.4A 2015-04-14 2018-07-09 治療b型肝炎病毒的方法 HK1249046A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562147400P 2015-04-14 2015-04-14
PCT/US2016/027354 WO2016168349A1 (en) 2015-04-14 2016-04-13 Methods of treating hepatitis b virus

Publications (1)

Publication Number Publication Date
HK1249046A1 true HK1249046A1 (zh) 2018-10-26

Family

ID=55806858

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108874.4A HK1249046A1 (zh) 2015-04-14 2018-07-09 治療b型肝炎病毒的方法

Country Status (9)

Country Link
US (2) US20160303095A1 (zh)
EP (1) EP3283076A1 (zh)
JP (1) JP2018511621A (zh)
AU (1) AU2016250099A1 (zh)
CA (1) CA2981856A1 (zh)
HK (1) HK1249046A1 (zh)
MA (1) MA43925A (zh)
TW (1) TW201700098A (zh)
WO (1) WO2016168349A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230130175A (ko) 2014-12-26 2023-09-11 에모리 유니버시티 Ｎ4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도
AU2018378832B9 (en) 2017-12-07 2021-05-27 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
WO2019154261A1 (zh) * 2018-02-09 2019-08-15 南京明德新药研发股份有限公司 与kmd5通路相关的吡啶衍生物
CN110057954B (zh) * 2019-04-30 2021-02-23 中国医学科学院病原生物学研究所 血浆代谢标志物在诊断或监测hbv的应用
JP7237311B2 (ja) * 2019-06-06 2023-03-13 京都府公立大学法人 化合物、医薬組成物、ｋｄｍ５ｃ阻害剤及び抗うつ剤
WO2020257733A1 (en) * 2019-06-20 2020-12-24 The Board Of Regents Of The University Of Texas System Histone demethylase inhibitors for treating cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010143582A1 (ja) * 2009-06-11 2010-12-16 公立大学法人名古屋市立大学 フェニルシクロプロピルアミン誘導体及びlsd1阻害剤
US9186337B2 (en) * 2010-02-24 2015-11-17 Oryzon Genomics S.A. Lysine demethylase inhibitors for diseases and disorders associated with Hepadnaviridae
CN104603125A (zh) * 2012-09-10 2015-05-06 弗·哈夫曼-拉罗切有限公司 用于治疗和预防乙型肝炎病毒感染的6-氨基酸杂芳基二氢嘧啶
CA2885969C (en) * 2012-10-02 2021-04-06 Epitherapeutics Aps Substitued pyridine derivatives and compositions thereof useful as inhibitors of histone demethylases
US9650339B2 (en) * 2013-02-27 2017-05-16 Gilead Sciences, Inc. Inhibitors of histone demethylases

Also Published As

Publication number Publication date
WO2016168349A1 (en) 2016-10-20
TW201700098A (zh) 2017-01-01
US20160303095A1 (en) 2016-10-20
JP2018511621A (ja) 2018-04-26
MA43925A (fr) 2018-12-05
EP3283076A1 (en) 2018-02-21
AU2016250099A1 (en) 2017-10-12
US20180042905A1 (en) 2018-02-15
CA2981856A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
IL280459A (en) Phosphoramidates for the treatment of hepatitis B virus
HK1258795A1 (zh) 絲狀病毒科病毒感染的治療方法
IL258697A (en) Methods related to crispr/cas and compositions for the treatment of viral hepatitis b
HK1247147A1 (zh) 氮雜環辛烷和氮雜環壬烷衍生物以及治療乙型肝炎感染的方法
IL246678A0 (en) History of Azpan and methods of treating jaundice b infections
ZA201900156B (en) Phosphoramidates for the treatment of hepatitis b virus
HK1231402A1 (zh) 治療 型肝炎和 型肝炎病毒感染的方法
HK1249046A1 (zh) 治療b型肝炎病毒的方法
SG10201913958QA (en) Modulation of hepatitis b virus replication
SI3137078T1 (sl) Zdravljenje okužbe s hepatitis delta virusom
HUE054191T2 (hu) A hepatitis delta vírusfertõzés kezelése
HK1249514A1 (zh) C型肝炎病毒聚合酶的抑制劑